➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
McKinsey
Harvard Business School
Mallinckrodt
Johnson and Johnson

Last Updated: April 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Mitoquinone

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Mitoquinone?

Mitoquinone is an investigational drug.

There have been 7 clinical trials for Mitoquinone. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2007.

The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, and Fatigue. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., University of Copenhagen, and VA Office of Research and Development.

Recent Clinical Trials for Mitoquinone
TitleSponsorPhase
Mitochondrial Dysfunction and Insulin Resistance in Skeletal MuscleUniversity of CopenhagenN/A
MitoQ for Fatigue in Multiple Sclerosis (MS)VA Office of Research and DevelopmentPhase 1/Phase 2
MitoQ on Fatigue in Multiple SclerosisMitoQ LtdPhase 1/Phase 2

See all Mitoquinone clinical trials

Clinical Trial Summary for Mitoquinone

Top disease conditions for Mitoquinone
Top clinical trial sponsors for Mitoquinone

See all Mitoquinone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
McKinsey
Harvard Business School
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.